These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 26362732)
21. Combination of gp130-targeting and TNF-targeting small molecules in alleviating arthritis through the down-regulation of Th17 differentiation and osteoclastogenesis. Park YH; Kim HJ; Lee K; Choi Y; Heo TH Biochem Biophys Res Commun; 2020 Feb; 522(4):1030-1036. PubMed ID: 31818460 [TBL] [Abstract][Full Text] [Related]
22. Interleukin (IL)-25 suppresses IL-22-induced osteoclastogenesis in rheumatoid arthritis via STAT3 and p38 MAPK/IκBα pathway. Min HK; Won JY; Kim BM; Lee KA; Lee SJ; Lee SH; Kim HR; Kim KW Arthritis Res Ther; 2020 Sep; 22(1):222. PubMed ID: 32972460 [TBL] [Abstract][Full Text] [Related]
23. CCAAT/enhancer-binding protein β promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis. Tsushima H; Okazaki K; Ishihara K; Ushijima T; Iwamoto Y Arthritis Res Ther; 2015 Feb; 17(1):31. PubMed ID: 25811130 [TBL] [Abstract][Full Text] [Related]
24. Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes. Kim YG; Lee CK; Oh JS; Kim SH; Kim KA; Yoo B Arthritis Rheum; 2010 Feb; 62(2):515-23. PubMed ID: 20112365 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways. Xu L; Feng X; Shi Y; Wang X; Kong X; Zhang M; Liu M; Tan W; Wang F Int J Rheum Dis; 2015 Nov; 18(8):842-9. PubMed ID: 26420479 [TBL] [Abstract][Full Text] [Related]
26. Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis. Kim HR; Kim KW; Jung HG; Yoon KS; Oh HJ; Cho ML; Lee SH Arthritis Res Ther; 2011 Mar; 13(2):R43. PubMed ID: 21401926 [TBL] [Abstract][Full Text] [Related]
27. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Takayanagi H; Iizuka H; Juji T; Nakagawa T; Yamamoto A; Miyazaki T; Koshihara Y; Oda H; Nakamura K; Tanaka S Arthritis Rheum; 2000 Feb; 43(2):259-69. PubMed ID: 10693864 [TBL] [Abstract][Full Text] [Related]
28. IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis. Park MK; Her YM; Cho ML; Oh HJ; Park EM; Kwok SK; Ju JH; Park KS; Min DS; Kim HY; Park SH Immunol Lett; 2011 Sep; 139(1-2):42-51. PubMed ID: 21620893 [TBL] [Abstract][Full Text] [Related]
29. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha. Dai SM; Nishioka K; Yudoh K Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886 [TBL] [Abstract][Full Text] [Related]
30. IL-32 and IL-17 interact and have the potential to aggravate osteoclastogenesis in rheumatoid arthritis. Moon YM; Yoon BY; Her YM; Oh HJ; Lee JS; Kim KW; Lee SY; Woo YJ; Park KS; Park SH; Kim HY; Cho ML Arthritis Res Ther; 2012 Nov; 14(6):R246. PubMed ID: 23148681 [TBL] [Abstract][Full Text] [Related]
31. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Hashizume M; Hayakawa N; Mihara M Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965 [TBL] [Abstract][Full Text] [Related]
32. Toll-like receptor 7 regulates osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim BM; Won JY; Lee KA; Kim HR; Lee SH J Biochem; 2019 Sep; 166(3):259-270. PubMed ID: 31086948 [TBL] [Abstract][Full Text] [Related]
33. Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Komano Y; Nanki T; Hayashida K; Taniguchi K; Miyasaka N Arthritis Res Ther; 2006; 8(5):R152. PubMed ID: 16987426 [TBL] [Abstract][Full Text] [Related]
34. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model. Ohtsuji M; Lin Q; Nishikawa K; Ohtsuji N; Okazaki H; Tsurui H; Amano H; Shirai T; Nishimoto N; Nishimura H; Hirose S Mod Rheumatol; 2015 Mar; 25(2):270-7. PubMed ID: 25159156 [TBL] [Abstract][Full Text] [Related]
35. Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Miranda-Carús ME; Benito-Miguel M; Balsa A; Cobo-Ibáñez T; Pérez de Ayala C; Pascual-Salcedo D; Martín-Mola E Arthritis Rheum; 2006 Apr; 54(4):1151-64. PubMed ID: 16575870 [TBL] [Abstract][Full Text] [Related]
36. Role of C-reactive protein in osteoclastogenesis in rheumatoid arthritis. Kim KW; Kim BM; Moon HW; Lee SH; Kim HR Arthritis Res Ther; 2015 Mar; 17(1):41. PubMed ID: 25889630 [TBL] [Abstract][Full Text] [Related]
37. CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Lee HY; Jeon HS; Song EK; Han MK; Park SI; Lee SI; Yun HJ; Kim JR; Kim JS; Lee YC; Kim SI; Kim HR; Choi JY; Kang I; Kim HY; Yoo WH Arthritis Rheum; 2006 Jun; 54(6):1747-58. PubMed ID: 16736517 [TBL] [Abstract][Full Text] [Related]
38. Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and, their heterogeneity and plasticity role in RA pathogenesis. Rana AK; Li Y; Dang Q; Yang F Int Immunopharmacol; 2018 Dec; 65():348-359. PubMed ID: 30366278 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling. Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358 [TBL] [Abstract][Full Text] [Related]
40. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation. Lavocat F; Osta B; Miossec P Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]